Andras G Lacko Selected Research

valrubicin (AD 32)

1/2017	Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery.
2/2016	Photophysical characterization of anticancer drug valrubicin in rHDL nanoparticles and its use as an imaging agent.
1/2012	Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andras G Lacko Research Topics

Disease

18	Neoplasms (Cancer) 01/2020 - 07/2002
2	Triple Negative Breast Neoplasms 01/2017 - 01/2013
2	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 02/2016
2	Urinary Bladder Neoplasms (Bladder Cancer) 02/2016 - 01/2012
2	Neoplasm Metastasis (Metastasis) 01/2016 - 04/2011
2	Carcinogenesis 01/2016 - 09/2013
2	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 08/2006 - 08/2004
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Leukemia 01/2014
1	Neuroblastoma 03/2013
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 04/2011
1	Corneal Opacity 08/2004
1	Anemia 08/2004
1	Renal Insufficiency (Renal Failure) 08/2004
1	Proteinuria 08/2004
1	Atherosclerosis 03/2004

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 01/2017 - 07/2002
7	HDL LipoproteinsIBA 01/2019 - 01/2010
5	Lipoproteins (Lipoprotein)IBA 01/2020 - 11/2007
5	Scavenger Receptors (Scavenger Receptor)IBA 01/2019 - 07/2002
4	CholesterolIBA 01/2019 - 08/2004
3	valrubicin (AD 32)FDA Link 01/2017 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 11/2007
2	Hormones (Hormone)IBA 01/2017 - 01/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2010 - 07/2002
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2016
1	RetinoidsIBA 03/2013
1	human ERBB2 proteinIBA 01/2013
1	Estrogen ReceptorsIBA 01/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2013
1	Drug CarriersIBA 05/2012
1	Antineoplastic Agents (Antineoplastics)IBA 01/2012
1	Small Interfering RNA (siRNA)IBA 04/2011
1	Focal Adhesion Protein-Tyrosine KinasesIBA 04/2011
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 04/2011
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 08/2006
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2004
1	Cholesterol Esters (Cholesteryl Esters)IBA 07/2002

Therapy/Procedure

7	Therapeutics 01/2019 - 08/2004
7	Drug Therapy (Chemotherapy) 01/2017 - 11/2007